December 1, 2007Modern Rheumatology

Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis

View Full Paper

Ask AI

Bookmark

Abstract

Tetsuo Kubota, Tokiko Nii, Toshihiro Nanki, Hitoshi Kohsaka, Masayoshi Harigai, Yukiko Komano, Takahiko Sugihara, Yoshinori Nonomura, Wataru Hirose, Kenji Nagas

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kubota et al. (2007) studied this question.

synapsesocial.com/papers/6a75b52312165deef3dd91c4 https://doi.org/10.1007/s10165-007-0632-5

View Full Paper

Ask AI

Bookmark

Abstract

Tetsuo Kubota, Tokiko Nii, Toshihiro Nanki, Hitoshi Kohsaka, Masayoshi Harigai, Yukiko Komano, Takahiko Sugihara, Yoshinori Nonomura, Wataru Hirose, Kenji Nagas

Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis

Abstract

Discussion

Cite This Study

Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis

Abstract

Discussion

Cite This Study

Keep reading

Keep reading